Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using same

US10351816B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10351816-B2
Application numberUS-201515736544-A
CountryUS
Kind codeB2
Filing dateNov 23, 2015
Priority dateNov 23, 2015
Publication dateJul 16, 2019
Grant dateJul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to application of a novel signal peptide in L-arginine and its derivatives production from konjac powder, which belongs to the field of gene engineering, enzyme engineering and metabolism engineering. The present invention fused the signal peptide set forth in SEQ ID NO.1 with the β-mannanase of Bacillus subtilis CCTCC M 209200, and expressed the fused gene in the strain with high L-arginine yield. The recombinant strain Corynebacterium crenatum CGMCC 0890/p MSPman had advantages on utilizing cheaper konjac powder as substrate, and after fermenting for 96 hours in a 5 L bioreactor, the L-arginine yield reached 45 g/L. Another two recombinant strains were constructed based on Corynebacterium crenatum CGMCC 0890/pMSPman, and after fermenting for 96 hours in a 5 L bioreactor, the L-ornithine yield and L-citrulline reached 23.5 g/L and 26.3 g/L respectively.

First claim

Opening claim text (preview).

The invention claimed is: 1. A mannase signal peptide that is encoded by a non-naturally occurring nucleotide sequence set forth in SEQ ID NO: 1, wherein the mannase signal peptide mediates secretion of beta-mannase.

Assignees

Inventors

Classifications

  • Beta-mannosidase (3.2.1.25), i.e. mannanase · CPC title

  • from Bacillus (G) · CPC title

  • C12P13/10Primary

    Citrulline; Arginine; Ornithine · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10351816B2 cover?
The present invention relates to application of a novel signal peptide in L-arginine and its derivatives production from konjac powder, which belongs to the field of gene engineering, enzyme engineering and metabolism engineering. The present invention fused the signal peptide set forth in SEQ ID NO.1 with the β-mannanase of Bacillus subtilis CCTCC M 209200, and expressed the fused gene in the …
Who is the assignee on this patent?
Univ Jiangnan
What technology area does this patent fall under?
Primary CPC classification C12P13/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).